Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1957 2
1958 2
1960 1
1961 1
1963 1
1966 1
1967 1
1970 3
1971 1
1972 2
1974 1
1976 1
1977 1
1979 2
1981 1
1982 1
1983 4
1984 4
1985 7
1986 7
1987 4
1988 4
1989 6
1990 8
1991 4
1992 13
1993 18
1994 22
1995 13
1996 25
1997 19
1998 28
1999 33
2000 43
2001 37
2002 48
2003 56
2004 78
2005 101
2006 106
2007 140
2008 155
2009 188
2010 276
2011 306
2012 365
2013 480
2014 555
2015 563
2016 678
2017 713
2018 792
2019 916
2020 1042
2021 1121
2022 1296
2023 21
Text availability
Article attribute
Article type
Publication date

Search Results

9,256 results
Results by year
Filters applied: . Clear all
Page 1
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.
Elamin YY, Robichaux JP, Carter BW, Altan M, Tran H, Gibbons DL, Heeke S, Fossella FV, Lam VK, Le X, Negrao MV, Nilsson MB, Patel A, Vijayan RSK, Cross JB, Zhang J, Byers LA, Lu C, Cascone T, Feng L, Luthra R, San Lucas FA, Mantha G, Routbort M, Blumenschein G Jr, Tsao AS, Heymach JV. Elamin YY, et al. Among authors: feng l. Cancer Cell. 2022 Jul 11;40(7):754-767.e6. doi: 10.1016/j.ccell.2022.06.006. Cancer Cell. 2022. PMID: 35820397 Free PMC article. Clinical Trial.
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
Westin J, Davis RE, Feng L, Hagemeister F, Steiner R, Lee HJ, Fayad L, Nastoupil L, Ahmed S, Rodriguez A, Fanale M, Samaniego F, Iyer SP, Nair R, Oki Y, Fowler N, Wang M, Ma MCJ, Vega F, McDonnell T, Pinnix C, Griffith D, Lu Y, Tewari S, Sun R, Scott DW, Flowers CR, Neelapu S, Green MR. Westin J, et al. Among authors: feng l. J Clin Oncol. 2022 Aug 11:JCO2200597. doi: 10.1200/JCO.22.00597. Online ahead of print. J Clin Oncol. 2022. PMID: 35952327
Polyrotaxanes and the pump paradigm.
Seale JSW, Feng Y, Feng L, Astumian RD, Stoddart JF. Seale JSW, et al. Among authors: feng l. Chem Soc Rev. 2022 Oct 17;51(20):8450-8475. doi: 10.1039/d2cs00194b. Chem Soc Rev. 2022. PMID: 36189715 Review.
Intracellular silicification by early-branching magnetotactic bacteria.
Li J, Liu P, Menguy N, Zhang X, Wang J, Benzerara K, Feng L, Sun L, Zheng Y, Meng F, Gu L, Leroy E, Hao J, Chu X, Pan Y. Li J, et al. Among authors: feng l. Sci Adv. 2022 May 13;8(19):eabn6045. doi: 10.1126/sciadv.abn6045. Epub 2022 May 13. Sci Adv. 2022. PMID: 35559677 Free PMC article.
Reflections on Changing COVID-19 Response Strategy in China.
Feng L, Wang Q, Yang W. Feng L, et al. Arch Bronconeumol. 2022 Nov;58(11):735-738. doi: 10.1016/j.arbres.2022.05.011. Epub 2022 Jun 10. Arch Bronconeumol. 2022. PMID: 35752555 Free PMC article. No abstract available.
9,256 results